#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Researchers identify protein responsible for malaria transmission
1-1	0-11	Researchers	person	new	coref	4-4
1-2	12-20	identify	_	_	_	_
1-3	21-28	protein	substance[2]	new[2]	coref	4-8[14_2]
1-4	29-40	responsible	substance[2]	new[2]	_	_
1-5	41-44	for	_	_	_	_
1-6	45-52	malaria	abstract|abstract[4]	new|new[4]	coref|coref	4-13|4-13[16_4]
1-7	53-65	transmission	abstract[4]	new[4]	_	_

#Text=Tuesday , February 25 , 2014
2-1	66-73	Tuesday	time	new	appos	2-3[7_0]
2-2	74-75	,	_	_	_	_
2-3	76-84	February	time|time[7]	new|giv[7]	_	_
2-4	85-87	25	time[7]	giv[7]	_	_
2-5	88-89	,	time[7]	giv[7]	_	_
2-6	90-94	2014	time[7]|time	giv[7]|new	_	_

#Text=Plasmodium falciparum gametocytes .
3-1	95-105	Plasmodium	substance|abstract[10]|animal[11]	new|new[10]|new[11]	coref|coref|coref	5-13[25_11]|7-5|9-19[48_10]
3-2	106-116	falciparum	abstract[10]|animal[11]	new[10]|new[11]	_	_
3-3	117-128	gametocytes	animal[11]	new[11]	_	_
3-4	129-130	.	_	_	_	_

#Text=Two groups of researchers have independently identified the the protein responsible for malaria transmission to mosquitoes in studies published in journal Nature on Sunday .
4-1	131-134	Two	person[12]	new[12]	_	_
4-2	135-141	groups	person[12]	new[12]	_	_
4-3	142-144	of	person[12]	new[12]	_	_
4-4	145-156	researchers	person[12]|person	new[12]|giv	coref	12-1[81_0]
4-5	157-161	have	_	_	_	_
4-6	162-175	independently	_	_	_	_
4-7	176-186	identified	_	_	_	_
4-8	187-190	the	substance[14]	giv[14]	coref	5-8[23_14]
4-9	191-194	the	substance[14]	giv[14]	_	_
4-10	195-202	protein	substance[14]	giv[14]	_	_
4-11	203-214	responsible	substance[14]	giv[14]	_	_
4-12	215-218	for	_	_	_	_
4-13	219-226	malaria	abstract|abstract[16]	giv|giv[16]	coref|coref	5-13|5-28[28_16]
4-14	227-239	transmission	abstract[16]	giv[16]	_	_
4-15	240-242	to	abstract[16]	giv[16]	_	_
4-16	243-253	mosquitoes	abstract[16]|animal[17]	giv[16]|new[17]	coref	6-6[30_17]
4-17	254-256	in	abstract[16]|animal[17]	giv[16]|new[17]	_	_
4-18	257-264	studies	abstract[16]|animal[17]|event	giv[16]|new[17]|new	_	_
4-19	265-274	published	_	_	_	_
4-20	275-277	in	_	_	_	_
4-21	278-285	journal	organization[19]	new[19]	_	_
4-22	286-292	Nature	organization[19]	new[19]	_	_
4-23	293-295	on	_	_	_	_
4-24	296-302	Sunday	time	new	_	_
4-25	303-304	.	_	_	_	_

#Text=The scientists found a direct relationship between the protein AP2-G 's with malaria gametocytes ( male and female sexual forms ) production , which is necessary for the transmission .
5-1	305-308	The	person[21]	new[21]	coref	9-39[52_21]
5-2	309-319	scientists	person[21]	new[21]	_	_
5-3	320-325	found	_	_	_	_
5-4	326-327	a	abstract[22]	new[22]	_	_
5-5	328-334	direct	abstract[22]	new[22]	_	_
5-6	335-347	relationship	abstract[22]	new[22]	_	_
5-7	348-355	between	abstract[22]	new[22]	_	_
5-8	356-359	the	abstract[22]|substance[23]	new[22]|giv[23]	coref	13-9[92_23]
5-9	360-367	protein	abstract[22]|substance[23]	new[22]|giv[23]	_	_
5-10	368-373	AP2-G	abstract[22]|substance[23]	new[22]|giv[23]	_	_
5-11	374-376	's	abstract[22]|substance[23]	new[22]|giv[23]	_	_
5-12	377-381	with	abstract[22]	new[22]	_	_
5-13	382-389	malaria	abstract[22]|abstract|animal[25]	new[22]|giv|giv[25]	coref|coref	7-1|12-29[0_25]
5-14	390-401	gametocytes	abstract[22]|animal[25]	new[22]|giv[25]	_	_
5-15	402-403	(	_	_	_	_
5-16	404-408	male	abstract[26]	new[26]	coref	6-2[29_26]
5-17	409-412	and	abstract[26]	new[26]	_	_
5-18	413-419	female	abstract[26]	new[26]	_	_
5-19	420-426	sexual	abstract[26]	new[26]	_	_
5-20	427-432	forms	abstract[26]	new[26]	_	_
5-21	433-434	)	_	_	_	_
5-22	435-445	production	abstract	new	_	_
5-23	446-447	,	_	_	_	_
5-24	448-453	which	_	_	_	_
5-25	454-456	is	_	_	_	_
5-26	457-466	necessary	_	_	_	_
5-27	467-470	for	_	_	_	_
5-28	471-474	the	abstract[28]	giv[28]	coref	14-10[97_28]
5-29	475-487	transmission	abstract[28]	giv[28]	_	_
5-30	488-489	.	_	_	_	_

#Text=Only the sexual forms infect mosquitoes and sexual reproduction occurs within the mosquito digestive tract .
6-1	490-494	Only	_	_	_	_
6-2	495-498	the	abstract[29]	giv[29]	coref	22-24[160_29]
6-3	499-505	sexual	abstract[29]	giv[29]	_	_
6-4	506-511	forms	abstract[29]	giv[29]	_	_
6-5	512-518	infect	_	_	_	_
6-6	519-529	mosquitoes	animal[30]	giv[30]	coref	20-35[134_30]
6-7	530-533	and	animal[30]	giv[30]	_	_
6-8	534-540	sexual	animal[30]|event[31]	giv[30]|new[31]	_	_
6-9	541-553	reproduction	animal[30]|event[31]	giv[30]|new[31]	_	_
6-10	554-560	occurs	_	_	_	_
6-11	561-567	within	_	_	_	_
6-12	568-571	the	object[33]	new[33]	_	_
6-13	572-580	mosquito	animal|object[33]	new|new[33]	coref	18-5[117_0]
6-14	581-590	digestive	object[33]	new[33]	_	_
6-15	591-596	tract	object[33]	new[33]	_	_
6-16	597-598	.	_	_	_	_

#Text=Malaria is caused by Plasmodium parasites .
7-1	599-606	Malaria	abstract	giv	coref	21-13[139_0]
7-2	607-609	is	_	_	_	_
7-3	610-616	caused	_	_	_	_
7-4	617-619	by	_	_	_	_
7-5	620-630	Plasmodium	substance|animal[36]	giv|new[36]	coref|coref	8-8|18-1[116_36]
7-6	631-640	parasites	animal[36]	new[36]	_	_
7-7	641-642	.	_	_	_	_

#Text=The initially separate teams looked at different plasmodium species .
8-1	643-646	The	organization[37]	new[37]	coref	17-1[107_37]
8-2	647-656	initially	organization[37]	new[37]	_	_
8-3	657-665	separate	organization[37]	new[37]	_	_
8-4	666-671	teams	organization[37]	new[37]	_	_
8-5	672-678	looked	_	_	_	_
8-6	679-681	at	_	_	_	_
8-7	682-691	different	animal[39]	new[39]	_	_
8-8	692-702	plasmodium	animal|animal[39]	giv|new[39]	coref	9-19
8-9	703-710	species	animal[39]	new[39]	_	_
8-10	711-712	.	_	_	_	_

#Text=One , an international group led by Manuel Llinás of Penn State University in the US , examined Plasmodium falciparum , which is responsible for the worst form of human malarial infections ; the other , led by UK scientists Oliver Billker from the Wellcome Trust Sanger Institute in England and Andy Waters from University of Glasgow in Scotland , looked at Plasmodium berghei , which infects rodents .
9-1	713-716	One	abstract	new	_	_
9-2	717-718	,	_	_	_	_
9-3	719-721	an	abstract[41]	new[41]	coref	10-1[65_41]
9-4	722-735	international	abstract[41]	new[41]	_	_
9-5	736-741	group	abstract[41]	new[41]	_	_
9-6	742-745	led	_	_	_	_
9-7	746-748	by	_	_	_	_
9-8	749-755	Manuel	person[42]	new[42]	_	_
9-9	756-762	Llinás	person[42]	new[42]	_	_
9-10	763-765	of	person[42]	new[42]	_	_
9-11	766-770	Penn	person[42]|place|organization[45]	new[42]|new|new[45]	_	_
9-12	771-776	State	person[42]|place|organization[45]	new[42]|new|new[45]	_	_
9-13	777-787	University	person[42]|organization[45]	new[42]|new[45]	_	_
9-14	788-790	in	person[42]|organization[45]	new[42]|new[45]	_	_
9-15	791-794	the	person[42]|organization[45]|place[46]	new[42]|new[45]|new[46]	_	_
9-16	795-797	US	person[42]|organization[45]|place[46]	new[42]|new[45]|new[46]	_	_
9-17	798-799	,	_	_	_	_
9-18	800-808	examined	_	_	_	_
9-19	809-819	Plasmodium	substance|animal[48]	giv|giv[48]	coref|coref	9-63|10-3[0_48]
9-20	820-830	falciparum	animal[48]	giv[48]	_	_
9-21	831-832	,	_	_	_	_
9-22	833-838	which	_	_	_	_
9-23	839-841	is	_	_	_	_
9-24	842-853	responsible	_	_	_	_
9-25	854-857	for	_	_	_	_
9-26	858-861	the	abstract[49]	new[49]	_	_
9-27	862-867	worst	abstract[49]	new[49]	_	_
9-28	868-872	form	abstract[49]	new[49]	_	_
9-29	873-875	of	abstract[49]	new[49]	_	_
9-30	876-881	human	abstract[49]|abstract[50]	new[49]|new[50]	_	_
9-31	882-890	malarial	abstract[49]|abstract[50]	new[49]|new[50]	_	_
9-32	891-901	infections	abstract[49]|abstract[50]	new[49]|new[50]	_	_
9-33	902-903	;	_	_	_	_
9-34	904-907	the	_	_	_	_
9-35	908-913	other	_	_	_	_
9-36	914-915	,	_	_	_	_
9-37	916-919	led	_	_	_	_
9-38	920-922	by	_	_	_	_
9-39	923-925	UK	place|person[52]	new|giv[52]	coref	25-8
9-40	926-936	scientists	person[52]	giv[52]	_	_
9-41	937-943	Oliver	person[52]	giv[52]	_	_
9-42	944-951	Billker	person[52]	giv[52]	_	_
9-43	952-956	from	person[52]	giv[52]	_	_
9-44	957-960	the	person[52]|organization[55]	giv[52]|new[55]	_	_
9-45	961-969	Wellcome	person[52]|organization|organization[55]	giv[52]|new|new[55]	_	_
9-46	970-975	Trust	person[52]|abstract|organization[55]	giv[52]|new|new[55]	_	_
9-47	976-982	Sanger	person[52]|organization[55]	giv[52]|new[55]	_	_
9-48	983-992	Institute	person[52]|organization[55]	giv[52]|new[55]	_	_
9-49	993-995	in	person[52]|organization[55]	giv[52]|new[55]	_	_
9-50	996-1003	England	person[52]|organization[55]|place	giv[52]|new[55]|new	coref	12-3
9-51	1004-1007	and	person[52]|organization[55]	giv[52]|new[55]	_	_
9-52	1008-1012	Andy	person[52]|organization[55]|person[57]	giv[52]|new[55]|new[57]	_	_
9-53	1013-1019	Waters	person[52]|organization[55]|person[57]	giv[52]|new[55]|new[57]	_	_
9-54	1020-1024	from	person[52]|organization[55]|person[57]	giv[52]|new[55]|new[57]	_	_
9-55	1025-1035	University	person[52]|organization[55]|person[57]|organization[58]	giv[52]|new[55]|new[57]|new[58]	_	_
9-56	1036-1038	of	person[52]|organization[55]|person[57]|organization[58]	giv[52]|new[55]|new[57]|new[58]	_	_
9-57	1039-1046	Glasgow	person[52]|organization[55]|person[57]|organization[58]|place	giv[52]|new[55]|new[57]|new[58]|new	_	_
9-58	1047-1049	in	person[52]|organization[55]|person[57]|organization[58]	giv[52]|new[55]|new[57]|new[58]	_	_
9-59	1050-1058	Scotland	person[52]|organization[55]|person[57]|organization[58]|place	giv[52]|new[55]|new[57]|new[58]|new	_	_
9-60	1059-1060	,	_	_	_	_
9-61	1061-1067	looked	_	_	_	_
9-62	1068-1070	at	_	_	_	_
9-63	1071-1081	Plasmodium	substance	giv	_	_
9-64	1082-1089	berghei	_	_	_	_
9-65	1090-1091	,	_	_	_	_
9-66	1092-1097	which	_	_	_	_
9-67	1098-1105	infects	_	_	_	_
9-68	1106-1113	rodents	animal	new	_	_
9-69	1114-1115	.	_	_	_	_

#Text=The P. falciparum group was kickstarted by research in Spain which found different organisms from the same strain with identical DNA had varying levels of AP2-G , with a strong correlation to their levels of sexual activity .
10-1	1116-1119	The	abstract[65]	giv[65]	_	_
10-2	1120-1122	P.	person|abstract[65]	new|giv[65]	coref	12-21
10-3	1123-1133	falciparum	animal|abstract[65]	giv|giv[65]	coref	12-21[87_0]
10-4	1134-1139	group	abstract[65]	giv[65]	_	_
10-5	1140-1143	was	_	_	_	_
10-6	1144-1155	kickstarted	_	_	_	_
10-7	1156-1158	by	_	_	_	_
10-8	1159-1167	research	abstract[66]	new[66]	coref	24-6[0_66]
10-9	1168-1170	in	abstract[66]	new[66]	_	_
10-10	1171-1176	Spain	abstract[66]|place	new[66]|new	_	_
10-11	1177-1182	which	_	_	_	_
10-12	1183-1188	found	_	_	_	_
10-13	1189-1198	different	animal[68]	new[68]	ana	10-33[0_68]
10-14	1199-1208	organisms	animal[68]	new[68]	_	_
10-15	1209-1213	from	animal[68]	new[68]	_	_
10-16	1214-1217	the	animal[68]|abstract[69]	new[68]|new[69]	coref	17-16[110_69]
10-17	1218-1222	same	animal[68]|abstract[69]	new[68]|new[69]	_	_
10-18	1223-1229	strain	animal[68]|abstract[69]	new[68]|new[69]	_	_
10-19	1230-1234	with	animal[68]|abstract[69]	new[68]|new[69]	_	_
10-20	1235-1244	identical	animal[68]|abstract[69]|abstract[70]	new[68]|new[69]|new[70]	_	_
10-21	1245-1248	DNA	animal[68]|abstract[69]|abstract[70]	new[68]|new[69]|new[70]	_	_
10-22	1249-1252	had	_	_	_	_
10-23	1253-1260	varying	abstract[71]	new[71]	_	_
10-24	1261-1267	levels	abstract[71]	new[71]	_	_
10-25	1268-1270	of	abstract[71]	new[71]	_	_
10-26	1271-1276	AP2-G	abstract[71]|abstract	new[71]|new	coref	11-1[77_0]
10-27	1277-1278	,	_	_	_	_
10-28	1279-1283	with	_	_	_	_
10-29	1284-1285	a	abstract[73]	new[73]	_	_
10-30	1286-1292	strong	abstract[73]	new[73]	_	_
10-31	1293-1304	correlation	abstract[73]	new[73]	_	_
10-32	1305-1307	to	abstract[73]	new[73]	_	_
10-33	1308-1313	their	abstract[73]|animal|abstract[75]	new[73]|giv|new[75]	_	_
10-34	1314-1320	levels	abstract[73]|abstract[75]	new[73]|new[75]	_	_
10-35	1321-1323	of	abstract[73]|abstract[75]	new[73]|new[75]	_	_
10-36	1324-1330	sexual	abstract[73]|abstract[75]|abstract[76]	new[73]|new[75]|new[76]	_	_
10-37	1331-1339	activity	abstract[73]|abstract[75]|abstract[76]	new[73]|new[75]|new[76]	_	_
10-38	1340-1341	.	_	_	_	_

#Text=The more AP2-G , the higher the rate of gametocyte formation .
11-1	1342-1345	The	abstract[77]	giv[77]	coref	13-10[0_77]
11-2	1346-1350	more	abstract[77]	giv[77]	_	_
11-3	1351-1356	AP2-G	abstract[77]	giv[77]	_	_
11-4	1357-1358	,	_	_	_	_
11-5	1359-1362	the	_	_	_	_
11-6	1363-1369	higher	_	_	_	_
11-7	1370-1373	the	abstract[78]	new[78]	_	_
11-8	1374-1378	rate	abstract[78]	new[78]	_	_
11-9	1379-1381	of	abstract[78]	new[78]	_	_
11-10	1382-1392	gametocyte	abstract[78]|animal|event[80]	new[78]|new|new[80]	coref	20-4[123_80]
11-11	1393-1402	formation	abstract[78]|event[80]	new[78]|new[80]	_	_
11-12	1403-1404	.	_	_	_	_

#Text=Researchers in England , later also drawn into the international team , analyzed the genomes of two mutated strains of P. falciparum which were both unable to form gametocytes .
12-1	1405-1416	Researchers	person[81]	giv[81]	ana	13-1[0_81]
12-2	1417-1419	in	person[81]	giv[81]	_	_
12-3	1420-1427	England	person[81]|place	giv[81]|giv	_	_
12-4	1428-1429	,	_	_	_	_
12-5	1430-1435	later	_	_	_	_
12-6	1436-1440	also	_	_	_	_
12-7	1441-1446	drawn	_	_	_	_
12-8	1447-1451	into	_	_	_	_
12-9	1452-1455	the	organization[83]	new[83]	coref	14-1[94_83]
12-10	1456-1469	international	organization[83]	new[83]	_	_
12-11	1470-1474	team	organization[83]	new[83]	_	_
12-12	1475-1476	,	_	_	_	_
12-13	1477-1485	analyzed	_	_	_	_
12-14	1486-1489	the	abstract[84]	new[84]	_	_
12-15	1490-1497	genomes	abstract[84]	new[84]	_	_
12-16	1498-1500	of	abstract[84]	new[84]	_	_
12-17	1501-1504	two	abstract[84]|abstract[85]	new[84]|new[85]	_	_
12-18	1505-1512	mutated	abstract[84]|abstract[85]	new[84]|new[85]	_	_
12-19	1513-1520	strains	abstract[84]|abstract[85]	new[84]|new[85]	_	_
12-20	1521-1523	of	abstract[84]|abstract[85]	new[84]|new[85]	_	_
12-21	1524-1526	P.	abstract[84]|abstract[85]|place|animal[87]	new[84]|new[85]|giv|giv[87]	_	_
12-22	1527-1537	falciparum	abstract[84]|abstract[85]|animal[87]	new[84]|new[85]|giv[87]	_	_
12-23	1538-1543	which	_	_	_	_
12-24	1544-1548	were	_	_	_	_
12-25	1549-1553	both	_	_	_	_
12-26	1554-1560	unable	_	_	_	_
12-27	1561-1563	to	_	_	_	_
12-28	1564-1568	form	abstract	new	none|none	12-28[0_146]|17-24
12-29	1569-1580	gametocytes	animal	giv	coref	17-25[113_0]
12-30	1581-1582	.	_	_	_	_

#Text=They found that the gene responsible for producing the AP2-G protein was the only common non-functioning gene .
13-1	1583-1587	They	person	giv	coref	24-1[162_0]
13-2	1588-1593	found	_	_	_	_
13-3	1594-1598	that	_	_	_	_
13-4	1599-1602	the	abstract[90]	new[90]	coref	13-13[93_90]
13-5	1603-1607	gene	abstract[90]	new[90]	_	_
13-6	1608-1619	responsible	abstract[90]	new[90]	_	_
13-7	1620-1623	for	_	_	_	_
13-8	1624-1633	producing	_	_	_	_
13-9	1634-1637	the	substance[92]	giv[92]	coref	14-6[96_92]
13-10	1638-1643	AP2-G	object|substance[92]	giv|giv[92]	coref	14-7
13-11	1644-1651	protein	substance[92]	giv[92]	_	_
13-12	1652-1655	was	_	_	_	_
13-13	1656-1659	the	abstract[93]	giv[93]	coref	14-16[0_93]
13-14	1660-1664	only	abstract[93]	giv[93]	_	_
13-15	1665-1671	common	abstract[93]	giv[93]	_	_
13-16	1672-1687	non-functioning	abstract[93]	giv[93]	_	_
13-17	1688-1692	gene	abstract[93]	giv[93]	_	_
13-18	1693-1694	.	_	_	_	_

#Text=The international team found found the AP2-G protein catalyzes the transmission by activating a relevant gene set in the parasite .
14-1	1695-1698	The	organization[94]	giv[94]	_	_
14-2	1699-1712	international	organization[94]	giv[94]	_	_
14-3	1713-1717	team	organization[94]	giv[94]	_	_
14-4	1718-1723	found	_	_	_	_
14-5	1724-1729	found	_	_	_	_
14-6	1730-1733	the	substance[96]	giv[96]	_	_
14-7	1734-1739	AP2-G	object|substance[96]	giv|giv[96]	_	_
14-8	1740-1747	protein	substance[96]	giv[96]	_	_
14-9	1748-1757	catalyzes	_	_	_	_
14-10	1758-1761	the	abstract[97]	giv[97]	coref	18-15[118_97]
14-11	1762-1774	transmission	abstract[97]	giv[97]	_	_
14-12	1775-1777	by	_	_	_	_
14-13	1778-1788	activating	_	_	_	_
14-14	1789-1790	a	abstract[99]	new[99]	_	_
14-15	1791-1799	relevant	abstract[99]	new[99]	_	_
14-16	1800-1804	gene	abstract|abstract[99]	giv|new[99]	coref	17-13[109_0]
14-17	1805-1808	set	abstract[99]	new[99]	_	_
14-18	1809-1811	in	abstract[99]	new[99]	_	_
14-19	1812-1815	the	abstract[99]|person[100]	new[99]|new[100]	coref	18-18[119_100]
14-20	1816-1824	parasite	abstract[99]|person[100]	new[99]|new[100]	_	_
14-21	1825-1826	.	_	_	_	_

#Text=Women tend to their malaria-infected babies in Angola .
15-1	1827-1832	Women	person	new	ana	15-4
15-2	1833-1837	tend	_	_	_	_
15-3	1838-1840	to	_	_	_	_
15-4	1841-1846	their	person|person[103]	giv|new[103]	_	_
15-5	1847-1863	malaria-infected	person[103]	new[103]	_	_
15-6	1864-1870	babies	person[103]	new[103]	_	_
15-7	1871-1873	in	person[103]	new[103]	_	_
15-8	1874-1880	Angola	person[103]|place	new[103]|new	_	_
15-9	1881-1882	.	_	_	_	_

#Text=Image : USAID Africa .
16-1	1883-1888	Image	object	new	_	_
16-2	1889-1890	:	_	_	_	_
16-3	1891-1896	USAID	organization	new	_	_
16-4	1897-1903	Africa	_	_	_	_
16-5	1904-1905	.	_	_	_	_

#Text=Both teams confirmed the finding by gene therapy — both by adding the gene into a mutated strain and observing its ability to form gametocytes , and the other way round .
17-1	1906-1910	Both	organization[107]	giv[107]	_	_
17-2	1911-1916	teams	organization[107]	giv[107]	_	_
17-3	1917-1926	confirmed	_	_	_	_
17-4	1927-1930	the	_	_	_	_
17-5	1931-1938	finding	_	_	_	_
17-6	1939-1941	by	_	_	_	_
17-7	1942-1946	gene	abstract[108]	new[108]	_	_
17-8	1947-1954	therapy	abstract[108]	new[108]	_	_
17-9	1955-1956	—	_	_	_	_
17-10	1957-1961	both	_	_	_	_
17-11	1962-1964	by	_	_	_	_
17-12	1965-1971	adding	_	_	_	_
17-13	1972-1975	the	abstract[109]	giv[109]	_	_
17-14	1976-1980	gene	abstract[109]	giv[109]	_	_
17-15	1981-1985	into	_	_	_	_
17-16	1986-1987	a	abstract[110]	giv[110]	ana	17-21[0_110]
17-17	1988-1995	mutated	abstract[110]	giv[110]	_	_
17-18	1996-2002	strain	abstract[110]	giv[110]	_	_
17-19	2003-2006	and	_	_	_	_
17-20	2007-2016	observing	_	_	_	_
17-21	2017-2020	its	abstract|abstract[112]	giv|new[112]	_	_
17-22	2021-2028	ability	abstract[112]	new[112]	_	_
17-23	2029-2031	to	_	_	_	_
17-24	2032-2036	form	abstract	new	coref	21-37[146_0]
17-25	2037-2048	gametocytes	animal[113]	giv[113]	coref	19-7[0_113]
17-26	2049-2050	,	animal[113]	giv[113]	_	_
17-27	2051-2054	and	animal[113]	giv[113]	_	_
17-28	2055-2058	the	animal[113]|event[115]	giv[113]|new[115]	_	_
17-29	2059-2064	other	animal[113]|place[114]|event[115]	giv[113]|new[114]|new[115]	_	_
17-30	2065-2068	way	animal[113]|place[114]|event[115]	giv[113]|new[114]|new[115]	_	_
17-31	2069-2074	round	animal[113]|event[115]	giv[113]|new[115]	_	_
17-32	2075-2076	.	_	_	_	_

#Text=The parasites exist in a mosquito , then in a human , and require subsequent transmission for the parasite to spread .
18-1	2077-2080	The	animal[116]	giv[116]	_	_
18-2	2081-2090	parasites	animal[116]	giv[116]	_	_
18-3	2091-2096	exist	_	_	_	_
18-4	2097-2099	in	_	_	_	_
18-5	2100-2101	a	animal[117]	giv[117]	_	_
18-6	2102-2110	mosquito	animal[117]	giv[117]	_	_
18-7	2111-2112	,	_	_	_	_
18-8	2113-2117	then	_	_	_	_
18-9	2118-2120	in	_	_	_	_
18-10	2121-2122	a	_	_	_	_
18-11	2123-2128	human	_	_	_	_
18-12	2129-2130	,	_	_	_	_
18-13	2131-2134	and	_	_	_	_
18-14	2135-2142	require	_	_	_	_
18-15	2143-2153	subsequent	abstract[118]	giv[118]	coref	19-1[120_118]
18-16	2154-2166	transmission	abstract[118]	giv[118]	_	_
18-17	2167-2170	for	abstract[118]	giv[118]	_	_
18-18	2171-2174	the	abstract[118]|person[119]	giv[118]|giv[119]	coref	20-1[122_119]
18-19	2175-2183	parasite	abstract[118]|person[119]	giv[118]|giv[119]	_	_
18-20	2184-2186	to	_	_	_	_
18-21	2187-2193	spread	_	_	_	_
18-22	2194-2195	.	_	_	_	_

#Text=The transmission can only happen through gametocytes .
19-1	2196-2199	The	abstract[120]	giv[120]	coref	21-10[138_120]
19-2	2200-2212	transmission	abstract[120]	giv[120]	_	_
19-3	2213-2216	can	_	_	_	_
19-4	2217-2221	only	_	_	_	_
19-5	2222-2228	happen	_	_	_	_
19-6	2229-2236	through	_	_	_	_
19-7	2237-2248	gametocytes	animal	giv	coref	20-6[124_0]
19-8	2249-2250	.	_	_	_	_

#Text=The parasite triggers formation of the sexual gametocytes into the human 's circulatory system every two days in small quantities — not wasting energy on the process at the dry time of year when few mosquitoes are available — but little was known about the mechanism .
20-1	2251-2254	The	person[122]	giv[122]	coref	20-11[125_122]
20-2	2255-2263	parasite	person[122]	giv[122]	_	_
20-3	2264-2272	triggers	_	_	_	_
20-4	2273-2282	formation	event[123]	giv[123]	_	_
20-5	2283-2285	of	event[123]	giv[123]	_	_
20-6	2286-2289	the	event[123]|animal[124]	giv[123]|giv[124]	_	_
20-7	2290-2296	sexual	event[123]|animal[124]	giv[123]|giv[124]	_	_
20-8	2297-2308	gametocytes	event[123]|animal[124]	giv[123]|giv[124]	_	_
20-9	2309-2313	into	event[123]|animal[124]	giv[123]|giv[124]	_	_
20-10	2314-2317	the	event[123]|animal[124]|place[127]	giv[123]|giv[124]|new[127]	_	_
20-11	2318-2323	human	event[123]|animal[124]|person[125]|place[127]	giv[123]|giv[124]|giv[125]|new[127]	coref	21-41[147_125]
20-12	2324-2326	's	event[123]|animal[124]|person[125]|place[127]	giv[123]|giv[124]|giv[125]|new[127]	_	_
20-13	2327-2338	circulatory	event[123]|animal[124]|place|place[127]	giv[123]|giv[124]|new|new[127]	_	_
20-14	2339-2345	system	event[123]|animal[124]|place[127]	giv[123]|giv[124]|new[127]	_	_
20-15	2346-2351	every	time[128]	new[128]	_	_
20-16	2352-2355	two	time[128]	new[128]	_	_
20-17	2356-2360	days	time[128]	new[128]	_	_
20-18	2361-2363	in	_	_	_	_
20-19	2364-2369	small	abstract[129]	new[129]	_	_
20-20	2370-2380	quantities	abstract[129]	new[129]	_	_
20-21	2381-2382	—	_	_	_	_
20-22	2383-2386	not	_	_	_	_
20-23	2387-2394	wasting	_	_	_	_
20-24	2395-2401	energy	abstract	new	_	_
20-25	2402-2404	on	_	_	_	_
20-26	2405-2408	the	abstract[131]	new[131]	_	_
20-27	2409-2416	process	abstract[131]	new[131]	_	_
20-28	2417-2419	at	_	_	_	_
20-29	2420-2423	the	time[132]	new[132]	_	_
20-30	2424-2427	dry	time[132]	new[132]	_	_
20-31	2428-2432	time	time[132]	new[132]	_	_
20-32	2433-2435	of	time[132]	new[132]	_	_
20-33	2436-2440	year	time[132]|time	new[132]|new	_	_
20-34	2441-2445	when	_	_	_	_
20-35	2446-2449	few	animal[134]	giv[134]	_	_
20-36	2450-2460	mosquitoes	animal[134]	giv[134]	_	_
20-37	2461-2464	are	_	_	_	_
20-38	2465-2474	available	_	_	_	_
20-39	2475-2476	—	_	_	_	_
20-40	2477-2480	but	_	_	_	_
20-41	2481-2487	little	_	_	_	_
20-42	2488-2491	was	_	_	_	_
20-43	2492-2497	known	_	_	_	_
20-44	2498-2503	about	_	_	_	_
20-45	2504-2507	the	abstract[135]	new[135]	_	_
20-46	2508-2517	mechanism	abstract[135]	new[135]	_	_
20-47	2518-2519	.	_	_	_	_

#Text=Dr. Oliver Billker commented on the potential of getting the transmission of malaria under control , unlike the existing focus on addressing the phrase causing the clinical symptoms , " Current drugs treat patients by killing the sexless form of the parasite in their blood — this is the detrimental stage of the malaria lifecycle that causes illness .
21-1	2520-2523	Dr.	person[136]	new[136]	_	_
21-2	2524-2530	Oliver	person[136]	new[136]	_	_
21-3	2531-2538	Billker	person[136]	new[136]	_	_
21-4	2539-2548	commented	_	_	_	_
21-5	2549-2551	on	_	_	_	_
21-6	2552-2555	the	abstract[137]	new[137]	_	_
21-7	2556-2565	potential	abstract[137]	new[137]	_	_
21-8	2566-2568	of	_	_	_	_
21-9	2569-2576	getting	_	_	_	_
21-10	2577-2580	the	abstract[138]	giv[138]	_	_
21-11	2581-2593	transmission	abstract[138]	giv[138]	_	_
21-12	2594-2596	of	abstract[138]	giv[138]	_	_
21-13	2597-2604	malaria	abstract[138]|abstract[139]	giv[138]|giv[139]	coref	21-54[0_139]
21-14	2605-2610	under	abstract[138]|abstract[139]	giv[138]|giv[139]	_	_
21-15	2611-2618	control	abstract[138]|abstract[139]|abstract	giv[138]|giv[139]|new	_	_
21-16	2619-2620	,	_	_	_	_
21-17	2621-2627	unlike	_	_	_	_
21-18	2628-2631	the	abstract[141]	new[141]	_	_
21-19	2632-2640	existing	abstract[141]	new[141]	_	_
21-20	2641-2646	focus	abstract[141]	new[141]	_	_
21-21	2647-2649	on	_	_	_	_
21-22	2650-2660	addressing	_	_	_	_
21-23	2661-2664	the	abstract[142]	new[142]	_	_
21-24	2665-2671	phrase	abstract[142]	new[142]	_	_
21-25	2672-2679	causing	_	_	_	_
21-26	2680-2683	the	abstract[143]	new[143]	_	_
21-27	2684-2692	clinical	abstract[143]	new[143]	_	_
21-28	2693-2701	symptoms	abstract[143]	new[143]	_	_
21-29	2702-2703	,	_	_	_	_
21-30	2704-2705	"	_	_	_	_
21-31	2706-2713	Current	substance[144]	new[144]	coref	24-8[0_144]
21-32	2714-2719	drugs	substance[144]	new[144]	_	_
21-33	2720-2725	treat	_	_	_	_
21-34	2726-2734	patients	person	new	ana	21-44
21-35	2735-2737	by	_	_	_	_
21-36	2738-2745	killing	_	_	_	_
21-37	2746-2749	the	abstract[146]	new[146]	_	_
21-38	2750-2757	sexless	abstract[146]	new[146]	_	_
21-39	2758-2762	form	abstract[146]	new[146]	_	_
21-40	2763-2765	of	abstract[146]	new[146]	_	_
21-41	2766-2769	the	abstract[146]|person[147]	new[146]|giv[147]	_	_
21-42	2770-2778	parasite	abstract[146]|person[147]	new[146]|giv[147]	_	_
21-43	2779-2781	in	abstract[146]|person[147]	new[146]|giv[147]	_	_
21-44	2782-2787	their	abstract[146]|person[147]|person|object[149]	new[146]|giv[147]|giv|new[149]	ana	21-47[0_149]
21-45	2788-2793	blood	abstract[146]|person[147]|object[149]	new[146]|giv[147]|new[149]	_	_
21-46	2794-2795	—	_	_	_	_
21-47	2796-2800	this	abstract	giv	coref	21-49[151_0]
21-48	2801-2803	is	_	_	_	_
21-49	2804-2807	the	abstract[151]	giv[151]	_	_
21-50	2808-2819	detrimental	abstract[151]	giv[151]	_	_
21-51	2820-2825	stage	abstract[151]	giv[151]	_	_
21-52	2826-2828	of	abstract[151]	giv[151]	_	_
21-53	2829-2832	the	abstract[151]|abstract[153]	giv[151]|new[153]	ana	22-3[0_153]
21-54	2833-2840	malaria	abstract[151]|abstract|abstract[153]	giv[151]|giv|new[153]	coref	22-11
21-55	2841-2850	lifecycle	abstract[151]|abstract[153]	giv[151]|new[153]	_	_
21-56	2851-2855	that	_	_	_	_
21-57	2856-2862	causes	_	_	_	_
21-58	2863-2870	illness	event	new	_	_
21-59	2871-2872	.	_	_	_	_

#Text=However , it is now widely accepted that to eliminate malaria from an entire region , it will be equally important to kill the sexual forms that transmit the disease .
22-1	2873-2880	However	_	_	_	_
22-2	2881-2882	,	_	_	_	_
22-3	2883-2885	it	abstract	giv	_	_
22-4	2886-2888	is	_	_	_	_
22-5	2889-2892	now	_	_	_	_
22-6	2893-2899	widely	_	_	_	_
22-7	2900-2908	accepted	_	_	_	_
22-8	2909-2913	that	_	_	_	_
22-9	2914-2916	to	_	_	_	_
22-10	2917-2926	eliminate	_	_	_	_
22-11	2927-2934	malaria	abstract	giv	coref	22-29[161_0]
22-12	2935-2939	from	_	_	_	_
22-13	2940-2942	an	place[157]	new[157]	_	_
22-14	2943-2949	entire	place[157]	new[157]	_	_
22-15	2950-2956	region	place[157]	new[157]	_	_
22-16	2957-2958	,	_	_	_	_
22-17	2959-2961	it	abstract	new	cata	22-17[0_159]
22-18	2962-2966	will	_	_	_	_
22-19	2967-2969	be	_	_	_	_
22-20	2970-2977	equally	_	_	_	_
22-21	2978-2987	important	_	_	_	_
22-22	2988-2990	to	abstract[159]	new[159]	_	_
22-23	2991-2995	kill	abstract[159]	new[159]	_	_
22-24	2996-2999	the	abstract[159]|abstract[160]	new[159]|giv[160]	_	_
22-25	3000-3006	sexual	abstract[159]|abstract[160]	new[159]|giv[160]	_	_
22-26	3007-3012	forms	abstract[159]|abstract[160]	new[159]|giv[160]	_	_
22-27	3013-3017	that	_	_	_	_
22-28	3018-3026	transmit	_	_	_	_
22-29	3027-3030	the	abstract[161]	giv[161]	coref	24-14[166_161]
22-30	3031-3038	disease	abstract[161]	giv[161]	_	_
22-31	3039-3040	.	_	_	_	_

#Text="
23-1	3041-3042	"	_	_	_	_

#Text=The researchers hope to continue research toward drugs to prevent the transmission of the disease .
24-1	3043-3046	The	person[162]	giv[162]	_	_
24-2	3047-3058	researchers	person[162]	giv[162]	_	_
24-3	3059-3063	hope	_	_	_	_
24-4	3064-3066	to	_	_	_	_
24-5	3067-3075	continue	_	_	_	_
24-6	3076-3084	research	abstract	giv	coref	25-9
24-7	3085-3091	toward	_	_	_	_
24-8	3092-3097	drugs	substance	giv	_	_
24-9	3098-3100	to	_	_	_	_
24-10	3101-3108	prevent	_	_	_	_
24-11	3109-3112	the	abstract[165]	new[165]	_	_
24-12	3113-3125	transmission	abstract[165]	new[165]	_	_
24-13	3126-3128	of	abstract[165]	new[165]	_	_
24-14	3129-3132	the	abstract[165]|abstract[166]	new[165]|giv[166]	_	_
24-15	3133-3140	disease	abstract[165]|abstract[166]	new[165]|giv[166]	_	_
24-16	3141-3142	.	_	_	_	_

#Text=The science was funded by groups including UK research councils , the Spanish government , the U.S. National Institutes of Health , and the European Commission .
25-1	3143-3146	The	abstract[167]	new[167]	_	_
25-2	3147-3154	science	abstract[167]	new[167]	_	_
25-3	3155-3158	was	_	_	_	_
25-4	3159-3165	funded	_	_	_	_
25-5	3166-3168	by	_	_	_	_
25-6	3169-3175	groups	person[168]	new[168]	_	_
25-7	3176-3185	including	person[168]	new[168]	_	_
25-8	3186-3188	UK	person[168]|place|organization[171]	new[168]|giv|new[171]	_	_
25-9	3189-3197	research	person[168]|abstract|organization[171]	new[168]|giv|new[171]	_	_
25-10	3198-3206	councils	person[168]|organization[171]	new[168]|new[171]	_	_
25-11	3207-3208	,	person[168]	new[168]	_	_
25-12	3209-3212	the	person[168]|organization[172]	new[168]|new[172]	_	_
25-13	3213-3220	Spanish	person[168]|organization[172]	new[168]|new[172]	_	_
25-14	3221-3231	government	person[168]|organization[172]	new[168]|new[172]	_	_
25-15	3232-3233	,	person[168]	new[168]	_	_
25-16	3234-3237	the	person[168]|organization[173]	new[168]|new[173]	_	_
25-17	3238-3242	U.S.	person[168]|organization[173]	new[168]|new[173]	_	_
25-18	3243-3251	National	person[168]|organization[173]	new[168]|new[173]	_	_
25-19	3252-3262	Institutes	person[168]|organization[173]	new[168]|new[173]	_	_
25-20	3263-3265	of	person[168]|organization[173]	new[168]|new[173]	_	_
25-21	3266-3272	Health	person[168]|organization[173]	new[168]|new[173]	_	_
25-22	3273-3274	,	person[168]	new[168]	_	_
25-23	3275-3278	and	person[168]	new[168]	_	_
25-24	3279-3282	the	person[168]|organization[174]	new[168]|new[174]	_	_
25-25	3283-3291	European	person[168]|organization[174]	new[168]|new[174]	_	_
25-26	3292-3302	Commission	person[168]|organization[174]	new[168]|new[174]	_	_
25-27	3303-3304	.	_	_	_	_
